Feedback / Questions
BHV-1510 - Biohaven
https://www.prnewswire.com/news-releases/biohaven-presents-oncology-program-updates-and-preliminary-clinical-data-showcasing-innovative-trop2-and-fgfr3-antibody-drug-conjugates-adcs-incorporating-novel-topoix-payload-with-potential-to-treat-a-wide-variety-of-tumors-302466505.html
May 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next